XML 15 R4.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Consolidated Statements of Operations - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Revenues    
Total revenues $ 23,252,000 $ 1,341,000
Operating Expenses    
Research and development 5,638,000 10,478,000
Selling, general and administrative 21,049,000 12,359,000
Total operating expenses 29,246,000 23,937,000
Operating loss (5,994,000) (22,596,000)
Other Income (Expense), Net    
Change in fair value of warrant liabilities 0 (32,481,000)
Interest expense (2,908,000) (1,000)
Interest income 683,000 918,000
Other income, net 290,000 7,000
Total other income (expense), net (1,935,000) (31,557,000)
Loss before income taxes (7,929,000) (54,153,000)
Income tax expense 0 0
Net loss $ (7,929,000) $ (54,153,000)
Net loss per share    
Net loss per share, basic (in dollars per share) $ (0.02) $ (0.18)
Net loss per share, diluted (in dollars per share) $ (0.02) $ (0.18)
Weighted average shares outstanding, basic (in shares) 354,291,007 293,879,653
Weighted average shares outstanding, diluted (in shares) 354,291,007 293,879,653
Product revenues, net    
Revenues    
Total revenues $ 21,828,000 $ 203,000
Service revenues    
Revenues    
Total revenues 1,424,000 1,138,000
Operating Expenses    
Cost of products and services $ 2,559,000 $ 1,100,000